Amylyx Pharmaceuticals (AMLX) Sets List Price of $12,500 for 28-Day Supply of ALS Drug Relyvrio -- WSJ
Tweet
Share
E-mail
Get Alerts AMLX Hot Sheet
Join SI Premium – FREE
Amylyx Pharmaceuticals (NASDAQ: AMLX) Sets List Price of $12,500 for 28-Day Supply of ALS Drug Relyvrio -- WSJ
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amylyx ALS drug shows no serious adverse events in Phase 1 trial
- Zeta Surgical begins TMS navigation treatments at Hope Therapeutics clinics
- TWO Announces Adjournment of Special Meeting
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
